0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global MEMS Ophthalmic Drug Delivery System Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-31N18759
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global MEMS Ophthalmic Drug Delivery System Market Research Report 2025
BUY CHAPTERS

Global MEMS Ophthalmic Drug Delivery System Market Research Report 2026

Code: QYRE-Auto-31N18759
Report
2026-01-22
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

MEMS Ophthalmic Drug Delivery System Market Size

The global MEMS Ophthalmic Drug Delivery System market was valued at US$ 354 million in 2025 and is anticipated to reach US$ 464 million by 2032, at a CAGR of 4.0% from 2026 to 2032.

MEMS Ophthalmic Drug Delivery System Market

MEMS Ophthalmic Drug Delivery System Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on MEMS Ophthalmic Drug Delivery System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
MEMS (Micro-Electro-Mechanical Systems) ophthalmic drug delivery system is an ocular drug delivery system designed using micro-electro-mechanical systems technology. This kind of system usually has the characteristics of small size, strong function, low price and high reliability. Among them, the micropump serves as the "heart" of the microsystem and provides the main power for fluid transportation.
The North American market for MEMS Ophthalmic Drug Delivery System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for MEMS Ophthalmic Drug Delivery System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of MEMS Ophthalmic Drug Delivery System include Mati Therapeutics, Amorphex Therapeutics, Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, inc., Gaplast GmbH, Gerresheimer, Nemera, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global MEMS Ophthalmic Drug Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding MEMS Ophthalmic Drug Delivery System. The MEMS Ophthalmic Drug Delivery System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global MEMS Ophthalmic Drug Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist MEMS Ophthalmic Drug Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of MEMS Ophthalmic Drug Delivery System Market Report

Report Metric Details
Report Name MEMS Ophthalmic Drug Delivery System Market
Accounted market size in 2025 US$ 354 million
Forecasted market size in 2032 US$ 464 million
CAGR 4.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Ophthalmic Mini Pump
  • Ophthalmic Injection Needle
  • Implantable Gel
  • Others
by Application
  • Hospital
  • Clinic
  • Home
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mati Therapeutics, Amorphex Therapeutics, Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for MEMS Ophthalmic Drug Delivery System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines MEMS Ophthalmic Drug Delivery System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is MEMS Ophthalmic Drug Delivery System Market growing?

Ans: The MEMS Ophthalmic Drug Delivery System Market witnessing a CAGR of 4.0% during the forecast period 2026-2032.

What is the MEMS Ophthalmic Drug Delivery System Market size in 2032?

Ans: The MEMS Ophthalmic Drug Delivery System Market size in 2032 will be US$ 464 million.

Who are the main players in the MEMS Ophthalmic Drug Delivery System Market report?

Ans: The main players in the MEMS Ophthalmic Drug Delivery System Market are Mati Therapeutics, Amorphex Therapeutics, Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix

What are the Application segmentation covered in the MEMS Ophthalmic Drug Delivery System Market report?

Ans: The Applications covered in the MEMS Ophthalmic Drug Delivery System Market report are Hospital, Clinic, Home

What are the Type segmentation covered in the MEMS Ophthalmic Drug Delivery System Market report?

Ans: The Types covered in the MEMS Ophthalmic Drug Delivery System Market report are Ophthalmic Mini Pump, Ophthalmic Injection Needle, Implantable Gel, Others

1 MEMS Ophthalmic Drug Delivery System Market Overview
1.1 Product Definition
1.2 MEMS Ophthalmic Drug Delivery System by Type
1.2.1 Global MEMS Ophthalmic Drug Delivery System Market Value by Type: 2025 vs 2032
1.2.2 Ophthalmic Mini Pump
1.2.3 Ophthalmic Injection Needle
1.2.4 Implantable Gel
1.2.5 Others
1.3 MEMS Ophthalmic Drug Delivery System by Application
1.3.1 Global MEMS Ophthalmic Drug Delivery System Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 Global MEMS Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global MEMS Ophthalmic Drug Delivery System Revenue 2021–2032
1.4.2 Global MEMS Ophthalmic Drug Delivery System Sales 2021–2032
1.4.3 Global MEMS Ophthalmic Drug Delivery System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 MEMS Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2021–2026)
2.2 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global MEMS Ophthalmic Drug Delivery System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of MEMS Ophthalmic Drug Delivery System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Product Types and Applications
2.7 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Date of Entry into the Industry
2.8 Global MEMS Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global MEMS Ophthalmic Drug Delivery System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global MEMS Ophthalmic Drug Delivery System Players Market Share by Revenue
2.8.3 Global MEMS Ophthalmic Drug Delivery System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global MEMS Ophthalmic Drug Delivery System Market Scenario by Region
3.1 Global MEMS Ophthalmic Drug Delivery System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global MEMS Ophthalmic Drug Delivery System Sales by Region: 2021–2032
3.2.1 Global MEMS Ophthalmic Drug Delivery System Sales by Region: 2021–2026
3.2.2 Global MEMS Ophthalmic Drug Delivery System Sales by Region: 2027–2032
3.3 Global MEMS Ophthalmic Drug Delivery System Revenue by Region: 2021–2032
3.3.1 Global MEMS Ophthalmic Drug Delivery System Revenue by Region: 2021–2026
3.3.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Region: 2027–2032
3.4 North America MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 North America MEMS Ophthalmic Drug Delivery System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America MEMS Ophthalmic Drug Delivery System Sales by Country (2021–2032)
3.4.3 North America MEMS Ophthalmic Drug Delivery System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe MEMS Ophthalmic Drug Delivery System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe MEMS Ophthalmic Drug Delivery System Sales by Country (2021–2032)
3.5.3 Europe MEMS Ophthalmic Drug Delivery System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific MEMS Ophthalmic Drug Delivery System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific MEMS Ophthalmic Drug Delivery System Sales by Region (2021–2032)
3.6.3 Asia Pacific MEMS Ophthalmic Drug Delivery System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America MEMS Ophthalmic Drug Delivery System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America MEMS Ophthalmic Drug Delivery System Sales by Country (2021–2032)
3.7.3 Latin America MEMS Ophthalmic Drug Delivery System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa MEMS Ophthalmic Drug Delivery System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa MEMS Ophthalmic Drug Delivery System Sales by Country (2021–2032)
3.8.3 Middle East and Africa MEMS Ophthalmic Drug Delivery System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2021–2032)
4.1.1 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2021–2026)
4.1.2 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2027–2032)
4.1.3 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Type (2021–2032)
4.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2021–2032)
4.2.1 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2021–2026)
4.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2027–2032)
4.2.3 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Type (2021–2032)
4.3 Global MEMS Ophthalmic Drug Delivery System Price by Type (2021–2032)
5 Segment by Application
5.1 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2021–2032)
5.1.1 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2021–2026)
5.1.2 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2027–2032)
5.1.3 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Application (2021–2032)
5.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2021–2032)
5.2.1 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2021–2026)
5.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2027–2032)
5.2.3 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Application (2021–2032)
5.3 Global MEMS Ophthalmic Drug Delivery System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mati Therapeutics
6.1.1 Mati Therapeutics Company Information
6.1.2 Mati Therapeutics Description and Business Overview
6.1.3 Mati Therapeutics MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mati Therapeutics MEMS Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Mati Therapeutics Recent Developments/Updates
6.2 Amorphex Therapeutics
6.2.1 Amorphex Therapeutics Company Information
6.2.2 Amorphex Therapeutics Description and Business Overview
6.2.3 Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Product Portfolio
6.2.5 Amorphex Therapeutics Recent Developments/Updates
6.3 Aero Pump GmbH
6.3.1 Aero Pump GmbH Company Information
6.3.2 Aero Pump GmbH Description and Business Overview
6.3.3 Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Aero Pump GmbH Recent Developments/Updates
6.4 AptarGroup
6.4.1 AptarGroup Company Information
6.4.2 AptarGroup Description and Business Overview
6.4.3 AptarGroup MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AptarGroup MEMS Ophthalmic Drug Delivery System Product Portfolio
6.4.5 AptarGroup Recent Developments/Updates
6.5 Bausch Health
6.5.1 Bausch Health Company Information
6.5.2 Bausch Health Description and Business Overview
6.5.3 Bausch Health MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Bausch Health MEMS Ophthalmic Drug Delivery System Product Portfolio
6.5.5 Bausch Health Recent Developments/Updates
6.6 Becton Dickinson & Company
6.6.1 Becton Dickinson & Company Company Information
6.6.2 Becton Dickinson & Company Description and Business Overview
6.6.3 Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Product Portfolio
6.6.5 Becton Dickinson & Company Recent Developments/Updates
6.7 EyePoint Pharmaceuticals, inc.
6.7.1 EyePoint Pharmaceuticals, inc. Company Information
6.7.2 EyePoint Pharmaceuticals, inc. Description and Business Overview
6.7.3 EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Product Portfolio
6.7.5 EyePoint Pharmaceuticals, inc. Recent Developments/Updates
6.8 Gaplast GmbH
6.8.1 Gaplast GmbH Company Information
6.8.2 Gaplast GmbH Description and Business Overview
6.8.3 Gaplast GmbH MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Gaplast GmbH MEMS Ophthalmic Drug Delivery System Product Portfolio
6.8.5 Gaplast GmbH Recent Developments/Updates
6.9 Gerresheimer
6.9.1 Gerresheimer Company Information
6.9.2 Gerresheimer Description and Business Overview
6.9.3 Gerresheimer MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Gerresheimer MEMS Ophthalmic Drug Delivery System Product Portfolio
6.9.5 Gerresheimer Recent Developments/Updates
6.10 Nemera
6.10.1 Nemera Company Information
6.10.2 Nemera Description and Business Overview
6.10.3 Nemera MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Nemera MEMS Ophthalmic Drug Delivery System Product Portfolio
6.10.5 Nemera Recent Developments/Updates
6.11 Nipro Corporation
6.11.1 Nipro Corporation Company Information
6.11.2 Nipro Corporation Description and Business Overview
6.11.3 Nipro Corporation MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Nipro Corporation MEMS Ophthalmic Drug Delivery System Product Portfolio
6.11.5 Nipro Corporation Recent Developments/Updates
6.12 Ocular Therapeutix
6.12.1 Ocular Therapeutix Company Information
6.12.2 Ocular Therapeutix Description and Business Overview
6.12.3 Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Product Portfolio
6.12.5 Ocular Therapeutix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MEMS Ophthalmic Drug Delivery System Industry Chain Analysis
7.2 MEMS Ophthalmic Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MEMS Ophthalmic Drug Delivery System Production Mode & Process Analysis
7.4 MEMS Ophthalmic Drug Delivery System Sales and Marketing
7.4.1 MEMS Ophthalmic Drug Delivery System Sales Channels
7.4.2 MEMS Ophthalmic Drug Delivery System Distributors
7.5 MEMS Ophthalmic Drug Delivery System Customer Analysis
8 MEMS Ophthalmic Drug Delivery System Market Dynamics
8.1 MEMS Ophthalmic Drug Delivery System Industry Trends
8.2 MEMS Ophthalmic Drug Delivery System Market Drivers
8.3 MEMS Ophthalmic Drug Delivery System Market Challenges
8.4 MEMS Ophthalmic Drug Delivery System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global MEMS Ophthalmic Drug Delivery System Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global MEMS Ophthalmic Drug Delivery System Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global MEMS Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers in 2025
 Table 4. Global MEMS Ophthalmic Drug Delivery System Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global MEMS Ophthalmic Drug Delivery System Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global MEMS Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market MEMS Ophthalmic Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of MEMS Ophthalmic Drug Delivery System, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Product Types and Applications
 Table 12. Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global MEMS Ophthalmic Drug Delivery System Companies by Tier (Tier 1, Tier 2, Tier 3), based on MEMS Ophthalmic Drug Delivery System Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global MEMS Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global MEMS Ophthalmic Drug Delivery System Sales by Region (K Units), 2021–2026
 Table 18. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Region (2021–2026)
 Table 19. Global MEMS Ophthalmic Drug Delivery System Sales by Region (K Units), 2027–2032
 Table 20. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Region (2027–2032)
 Table 21. Global MEMS Ophthalmic Drug Delivery System Revenue by Region (US$ Million), 2021–2026
 Table 22. Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Region (2021–2026)
 Table 23. Global MEMS Ophthalmic Drug Delivery System Revenue by Region (US$ Million), 2027–2032
 Table 24. Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Region (2027–2032)
 Table 25. North America MEMS Ophthalmic Drug Delivery System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2021–2026
 Table 27. North America MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2027–2032
 Table 28. North America MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2021–2026
 Table 29. North America MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe MEMS Ophthalmic Drug Delivery System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2021–2026
 Table 32. Europe MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2027–2032
 Table 33. Europe MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific MEMS Ophthalmic Drug Delivery System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific MEMS Ophthalmic Drug Delivery System Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific MEMS Ophthalmic Drug Delivery System Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific MEMS Ophthalmic Drug Delivery System Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific MEMS Ophthalmic Drug Delivery System Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America MEMS Ophthalmic Drug Delivery System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2021–2026
 Table 42. Latin America MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2027–2032
 Table 43. Latin America MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa MEMS Ophthalmic Drug Delivery System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa MEMS Ophthalmic Drug Delivery System Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa MEMS Ophthalmic Drug Delivery System Revenue by Country (US$ Million), 2027–2032
 Table 50. Global MEMS Ophthalmic Drug Delivery System Sales (K Units) by Type (2021–2026)
 Table 51. Global MEMS Ophthalmic Drug Delivery System Sales (K Units) by Type (2027–2032)
 Table 52. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Type (2021–2026)
 Table 53. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Type (2027–2032)
 Table 54. Global MEMS Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global MEMS Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Type (2021–2026)
 Table 57. Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Type (2027–2032)
 Table 58. Global MEMS Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2021–2026)
 Table 59. Global MEMS Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2027–2032)
 Table 60. Global MEMS Ophthalmic Drug Delivery System Sales (K Units) by Application (2021–2026)
 Table 61. Global MEMS Ophthalmic Drug Delivery System Sales (K Units) by Application (2027–2032)
 Table 62. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Application (2021–2026)
 Table 63. Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Application (2027–2032)
 Table 64. Global MEMS Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global MEMS Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Application (2021–2026)
 Table 67. Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Application (2027–2032)
 Table 68. Global MEMS Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2021–2026)
 Table 69. Global MEMS Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2027–2032)
 Table 70. Mati Therapeutics Company Information
 Table 71. Mati Therapeutics Description and Business Overview
 Table 72. Mati Therapeutics MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Mati Therapeutics MEMS Ophthalmic Drug Delivery System Product
 Table 74. Mati Therapeutics Recent Developments/Updates
 Table 75. Amorphex Therapeutics Company Information
 Table 76. Amorphex Therapeutics Description and Business Overview
 Table 77. Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Product
 Table 79. Amorphex Therapeutics Recent Developments/Updates
 Table 80. Aero Pump GmbH Company Information
 Table 81. Aero Pump GmbH Description and Business Overview
 Table 82. Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Product
 Table 84. Aero Pump GmbH Recent Developments/Updates
 Table 85. AptarGroup Company Information
 Table 86. AptarGroup Description and Business Overview
 Table 87. AptarGroup MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. AptarGroup MEMS Ophthalmic Drug Delivery System Product
 Table 89. AptarGroup Recent Developments/Updates
 Table 90. Bausch Health Company Information
 Table 91. Bausch Health Description and Business Overview
 Table 92. Bausch Health MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Bausch Health MEMS Ophthalmic Drug Delivery System Product
 Table 94. Bausch Health Recent Developments/Updates
 Table 95. Becton Dickinson & Company Company Information
 Table 96. Becton Dickinson & Company Description and Business Overview
 Table 97. Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Product
 Table 99. Becton Dickinson & Company Recent Developments/Updates
 Table 100. EyePoint Pharmaceuticals, inc. Company Information
 Table 101. EyePoint Pharmaceuticals, inc. Description and Business Overview
 Table 102. EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Product
 Table 104. EyePoint Pharmaceuticals, inc. Recent Developments/Updates
 Table 105. Gaplast GmbH Company Information
 Table 106. Gaplast GmbH Description and Business Overview
 Table 107. Gaplast GmbH MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Gaplast GmbH MEMS Ophthalmic Drug Delivery System Product
 Table 109. Gaplast GmbH Recent Developments/Updates
 Table 110. Gerresheimer Company Information
 Table 111. Gerresheimer Description and Business Overview
 Table 112. Gerresheimer MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Gerresheimer MEMS Ophthalmic Drug Delivery System Product
 Table 114. Gerresheimer Recent Developments/Updates
 Table 115. Nemera Company Information
 Table 116. Nemera Description and Business Overview
 Table 117. Nemera MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Nemera MEMS Ophthalmic Drug Delivery System Product
 Table 119. Nemera Recent Developments/Updates
 Table 120. Nipro Corporation Company Information
 Table 121. Nipro Corporation Description and Business Overview
 Table 122. Nipro Corporation MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Nipro Corporation MEMS Ophthalmic Drug Delivery System Product
 Table 124. Nipro Corporation Recent Developments/Updates
 Table 125. Ocular Therapeutix Company Information
 Table 126. Ocular Therapeutix Description and Business Overview
 Table 127. Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Product
 Table 129. Ocular Therapeutix Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. MEMS Ophthalmic Drug Delivery System Distributors List
 Table 133. MEMS Ophthalmic Drug Delivery System Customers List
 Table 134. MEMS Ophthalmic Drug Delivery System Market Trends
 Table 135. MEMS Ophthalmic Drug Delivery System Market Drivers
 Table 136. MEMS Ophthalmic Drug Delivery System Market Challenges
 Table 137. MEMS Ophthalmic Drug Delivery System Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of MEMS Ophthalmic Drug Delivery System
 Figure 2. Global MEMS Ophthalmic Drug Delivery System Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global MEMS Ophthalmic Drug Delivery System Market Share by Type: 2025 & 2032
 Figure 4. Ophthalmic Mini Pump Product Picture
 Figure 5. Ophthalmic Injection Needle Product Picture
 Figure 6. Implantable Gel Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global MEMS Ophthalmic Drug Delivery System Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global MEMS Ophthalmic Drug Delivery System Market Share by Application: 2025 & 2032
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Home
 Figure 13. Global MEMS Ophthalmic Drug Delivery System Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global MEMS Ophthalmic Drug Delivery System Market Size (US$ Million), 2021–2032
 Figure 15. Global MEMS Ophthalmic Drug Delivery System Sales (K Units), 2021–2032
 Figure 16. Global MEMS Ophthalmic Drug Delivery System Average Price (US$/Unit), 2021–2032
 Figure 17. MEMS Ophthalmic Drug Delivery System Report Years Considered
 Figure 18. MEMS Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2025
 Figure 19. Global MEMS Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global MEMS Ophthalmic Drug Delivery System Players: Market Share by Revenue in MEMS Ophthalmic Drug Delivery System in 2025
 Figure 21. MEMS Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global MEMS Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America MEMS Ophthalmic Drug Delivery System Sales Market Share by Country (2021–2032)
 Figure 24. North America MEMS Ophthalmic Drug Delivery System Revenue Market Share by Country (2021–2032)
 Figure 25. United States MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe MEMS Ophthalmic Drug Delivery System Sales Market Share by Country (2021–2032)
 Figure 28. Europe MEMS Ophthalmic Drug Delivery System Revenue Market Share by Country (2021–2032)
 Figure 29. Germany MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific MEMS Ophthalmic Drug Delivery System Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific MEMS Ophthalmic Drug Delivery System Revenue Market Share by Region (2021–2032)
 Figure 36. China MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America MEMS Ophthalmic Drug Delivery System Sales Market Share by Country (2021–2032)
 Figure 44. Latin America MEMS Ophthalmic Drug Delivery System Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa MEMS Ophthalmic Drug Delivery System Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa MEMS Ophthalmic Drug Delivery System Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE MEMS Ophthalmic Drug Delivery System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of MEMS Ophthalmic Drug Delivery System by Type (2021–2032)
 Figure 55. Global Revenue Market Share of MEMS Ophthalmic Drug Delivery System by Type (2021–2032)
 Figure 56. Global MEMS Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of MEMS Ophthalmic Drug Delivery System by Application (2021–2032)
 Figure 58. Global Revenue Market Share of MEMS Ophthalmic Drug Delivery System by Application (2021–2032)
 Figure 59. Global MEMS Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2021–2032)
 Figure 60. MEMS Ophthalmic Drug Delivery System Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS